---
figid: PMC7961955__ijms-22-02623-g007
figtitle: Common signaling pathways in liver disease (primarily HCC) and the kinase
  inhibitors aimed at these pathways
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC7961955
filename: ijms-22-02623-g007.jpg
figlink: pmc/articles/PMC7961955/figure/ijms-22-02623-f007/
number: F7
caption: 'Common signaling pathways in liver disease (primarily HCC) and the kinase
  inhibitors aimed at these pathways. Receptor tyrosine kinase (RTK) inhibitors are
  the main group of kinase inhibitors currently used in clinical practice. Most RTKs
  activate common downstream pathways: the JAK/STAT pathway, the mitogenic Ras/Raf/MEK/ERK
  pathway, and the PI3K/PKB survival pathway. These pathways show considerable overlap,
  with Src activating several of their members, and the guanine nucleotide exchange
  factor SOS being a target for both the adaptor protein Grb (activated via RTKs)
  and the oncogene Bcr-Abl (Figure based on [,]).'
papertitle: Drug Discovery in Liver Disease Using Kinome Profiling.
reftext: Bingting Yu, et al. Int J Mol Sci. 2021 Mar;22(5):2623.
year: '2021'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9635992
figid_alias: PMC7961955__F7
figtype: Figure
redirect_from: /figures/PMC7961955__F7
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7961955__ijms-22-02623-g007.html
  '@type': Dataset
  description: 'Common signaling pathways in liver disease (primarily HCC) and the
    kinase inhibitors aimed at these pathways. Receptor tyrosine kinase (RTK) inhibitors
    are the main group of kinase inhibitors currently used in clinical practice. Most
    RTKs activate common downstream pathways: the JAK/STAT pathway, the mitogenic
    Ras/Raf/MEK/ERK pathway, and the PI3K/PKB survival pathway. These pathways show
    considerable overlap, with Src activating several of their members, and the guanine
    nucleotide exchange factor SOS being a target for both the adaptor protein Grb
    (activated via RTKs) and the oncogene Bcr-Abl (Figure based on [,]).'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Tie
  - Ras85D
  - InR
  - Egfr
  - Src42A
  - Csk
  - Src64B
  - hop
  - bsk
  - Pvr
  - Ret
  - reticulated
  - reti
  - rets
  - grb
  - Sos
  - ras
  - Ras64B
  - ra
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Akt
  - blo
  - Stat92E
  - Raf
  - Mtor
  - Tor
  - Dsor1
  - Mtk
  - btl
  - htl
  - Erk7
  - rl
  - EGFR
  - SRC
  - FGR
  - FYN
  - YES1
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - KDR
  - FLT1
  - FLT4
  - RET
  - FLT3
  - XYLT2
  - SOS1
  - SOS2
  - KRAS
  - HRAS
  - NRAS
  - ABL1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - PTK2B
  - KIT
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - AXL
  - MTOR
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - FGFR1
  - FGFR2
  - FGFR3
  - FGFR4
  - FGFRL1
  - EPHB2
  - MAPK1
  - MAPK3
  - Erlotinib
  - Gefitinib
  - Lapatinib
  - Vandetanib
  - PI(3,4,5)P
  - Axitinib
  - Desatinib
  - Sorafinib
  - Sunitinib
  - Cabozantinib
  - Tofacitinib
  - Nilotinib
  - Imatinib
  - Regorafinib
---
